| Natural oils for skin-barrier repair: Ancient compounds now backed by modern science AR Vaughn, AK Clark, RK Sivamani, VY Shi American journal of clinical dermatology 19 (1), 103-117, 2018 | 173 | 2018 |
| Role of sebaceous glands in inflammatory dermatoses VY Shi, M Leo, L Hassoun, DS Chahal, HI Maibach, RK Sivamani Journal of the American Academy of Dermatology 73 (5), 856-863, 2015 | 135 | 2015 |
| COVID-19 and immunomodulator/immunosuppressant use in dermatology KN Price, JW Frew, JL Hsiao, VY Shi Journal of the American academy of dermatology 82 (5), e173-e175, 2020 | 122 | 2020 |
| Epithelial barrier dysfunctions in atopic dermatitis: a skin–gut–lung model linking microbiome alteration and immune dysregulation TH Zhu, TR Zhu, KA Tran, RK Sivamani, VY Shi British Journal of Dermatology 179 (3), 570-581, 2018 | 105 | 2018 |
| A comparison of international management guidelines for hidradenitis suppurativa AJ Hendricks, JL Hsiao, MA Lowes, VY Shi Dermatology 237 (1), 81-96, 2021 | 96 | 2021 |
| Paraneoplastic pemphigus and autoimmune blistering diseases associated with neoplasm: characteristics, diagnosis, associated neoplasms, proposed pathogenesis, treatment S Kartan, VY Shi, AK Clark, LS Chan American Journal of Clinical Dermatology 18, 105-126, 2017 | 80 | 2017 |
| Dupilumab use in dermatologic conditions beyond atopic dermatitis–a systematic review AJ Hendricks, G Yosipovitch, VY Shi Journal of Dermatological Treatment 32 (1), 19-28, 2021 | 74 | 2021 |
| Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials M Maarouf, AK Clark, DE Lee, VY Shi Journal of Dermatological Treatment 29 (5), 441-449, 2018 | 69 | 2018 |
| Topical probiotics: the unknowns behind their rising popularity GR Lee, M Maarouf, AJ Hendricks, DE Lee, VY Shi Dermatology Online Journal 25 (5), 2019 | 68 | 2019 |
| Current and emerging therapies for hand eczema GR Lee, M Maarouf, AK Hendricks, DE Lee, VY Shi Dermatologic Therapy 32 (3), e12840, 2019 | 67 | 2019 |
| A comparison of international management guidelines for atopic dermatitis LM LePoidevin, DE Lee, VY Shi Pediatric dermatology 36 (1), 36-65, 2019 | 67 | 2019 |
| The impact of airborne pollution on atopic dermatitis: a literature review AJ Hendricks, LF Eichenfield, VY Shi British Journal of Dermatology 183 (1), 16-23, 2020 | 63 | 2020 |
| Micronutrients in atopic dermatitis: a systematic review AR Vaughn, N Foolad, M Maarouf, KA Tran, VY Shi The Journal of Alternative and Complementary Medicine 25 (6), 567-577, 2019 | 63 | 2019 |
| IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of … L Bao, VY Shi, LS Chan Cytokine 61 (2), 419-425, 2013 | 62 | 2013 |
| The impact of stress on epidermal barrier function: an evidence‐based review M Maarouf, CL Maarouf, G Yosipovitch, VY Shi British Journal of Dermatology 181 (6), 1129-1137, 2019 | 60 | 2019 |
| Improving patient education with an eczema action plan: a randomized controlled trial VY Shi, S Nanda, K Lee, AW Armstrong, PA Lio JAMA dermatology 149 (4), 481-483, 2013 | 60 | 2013 |
| Hidradenitis suppurativa: disease burden and etiology in skin of color DE Lee, AK Clark, VY Shi Dermatology 233 (6), 456-461, 2018 | 59 | 2018 |
| MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy KA Tran, MY Cheng, A Mitra, H Ogawa, VY Shi, LP Olney, AM Kloxin, ... Drug design, development and therapy, 43-52, 2015 | 59 | 2015 |
| The role of nutrition in inflammatory pilosebaceous disorders: Implication of the skin‐gut axis M Maarouf, JF Platto, VY Shi Australasian Journal of Dermatology 60 (2), e90-e98, 2019 | 58 | 2019 |
| IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis L Bao, VY Shi, LS Chan Molecular immunology 50 (1-2), 91-97, 2012 | 56 | 2012 |
